| Ref ID | 562 |
| First Author | Z. Xinke |
| Journal | SYSTEMATIC REVIEWS |
| Year Of Publishing | 2016 |
| URL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072301/pdf/13643_2016_Article_353.pdf |
| Keywords |
• Risk of bias • Disclosure • Low methodological quality • Low reporting quality • Publication bias • Grey literature • Protocols • Complementary & Alternative |
| Problem(s) |
• Low methodological (AMSTAR) quality • Flawed risk of bias undertaken • Poor consideration of publication bias • Conflict of interest statement or disclosures for review authors missing • No registered or published protocol • Grey literature excluded • Search strategy not provided • Individual study characteristics not reported sufficiently |
| Article Type | Empirical |
| Article Subtype | Cross-sectional survey/Methodological systematic review |
| First Author Country | China |
| Checklists |
• AMSTAR 1 • GRADE |
| Aim | To assess the methodological quality of systematic reviews of Chinese herbal medicine for primary hypertension using AMSTAR and GRADE published between 2006-2014 |
| Level of Investigation | Descriptive |
| Summary of Findings | Low AMSTAR quality was found across several domains including No registered or published protocol; Conflict of interest statement or disclosures for review authors missing; Grey literature excluded; Search strategy not provided; Individual study characteristics not reported sufficiently; Low methodological (AMSTAR) quality; Flawed risk of bias undertaken; Poor consideration of publication bias |
| Number of systematic reviews included | 12 |
| Number of eligible systematic reviews assessed | 2260 |
| Treatment impacted | No |
| Treatment impacted description | |
| Interpretation impacted | Not Applicable |
| Interpretation impacted description |